Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,590 | -56,204 | -25,329 | -14,487 | -5,462 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1 |
| Accounts receivable | N/A | N/A | N/A | N/A | 735 |
| Accounts payable and accrued liabilities | 1,013 | -2,668 | 3,273 | 346 | -696 |
| Other Working Capital | 682 | -229 | -1,137 | 657 | -401 |
| Other Operating Activity | 1,001 | 19,134 | 5,879 | 4,351 | 1,852 |
| Operating Cash Flow | $-21,895 | $-39,967 | $-17,313 | $-9,132 | $-3,971 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,692 | 17,344 | 5 | 46,744 | 12,044 |
| Financing Cash Flow | $26,692 | $17,344 | $5 | $46,744 | $12,044 |
| Beginning Cash Position | 5,755 | 28,378 | 45,686 | 8,075 | 2 |
| End Cash Position | 10,552 | 5,755 | 28,378 | 45,686 | 8,075 |
| Net Cash Flow | $4,797 | $-22,623 | $-17,308 | $37,611 | $8,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,895 | -39,967 | -17,313 | -9,132 | -3,971 |
| Free Cash Flow | -21,895 | -39,967 | -17,313 | -9,132 | -3,971 |